FB2025_01 , released February 20, 2025
Allele: Dmel\GlyRSP234KY.UAS.Tag:HA
Open Close
General Information
Symbol
Dmel\GlyRSP234KY.UAS.Tag:HA
Species
D. melanogaster
Name
FlyBase ID
FBal0297470
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Transgenic product class
Nature of the Allele
Transgenic product class
Carried in construct
Cytology
Description

A P234KY amino acid replacement has been introduced into GlyRSUAS.Tag:HA.

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Comment:

P32KYmutation. Mutation in analogous codon in human GARS implicated in Charcot-Marie-Tooth disease, type 2D; mutation carried on in vitro construct; site of nucleotide substitution in fly gene inferred by FlyBase curator based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 1 )
Modifiers Based on Experimental Evidence ( 1 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
This allele represents a human variant implicated in disease.
GARS1:p.Pro288delinsLysTyr
Variants Synonym(s)
GARS1:p.Pro234delinsLysTyr
Associated human disease model(s)
External database links
Comments concerning this variant

Analogous to a disease variant in mouse.

Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Scer\GAL41032.hx Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 escapers (raised at 25[o]C) fail to expand their wings.

Scer\GAL41032.hx, Scer\GAL4elav.PU, Scer\GAL4how-24B or Scer\GAL4Mhc.PU-mediated expression results in reduced larval muscle contractions. This is seen when larvae are raised at 20 or 25o[C] in all cases except Scer\GAL4elav.PU, where the effect is only seen at 25[o]C.

Scer\GAL41032.hx-mediated expression results in reduced bouton number and increased bouton size at larval neuromuscular junctions. Scer\GAL4how-24B or Scer\GAL4Mhc.PU-mediated, but not Scer\GAL4elav.PU-mediated expression also reduces bouton number. Synaptic denervation and axon degeneration are also apparent in these animals. No gross changes in muscle size or structure are observed.

Ubiquitous expression of Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of either a strong Act5C driver (the P{Act5C-GAL4}25FO1 insertion of Scer\GAL4Act5C.PI) or a weaker one (P{Act5C-GAL4}17bFO1) induces lethality at the first instar larval stage and no adult flies emerge. Expression in the nervous system under the control of Scer\GAL4nSyb.PS reach the late stage of pupal development.

Flies expressing Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4OK307 exhibit defects in the Giant Fibre-Trochanteral-Motoneuron-Tergotrochanteral Muscle (GF-TTMn-TTM) circuit. Upon GF stimulation, 40% of recordings show complete absence of the TTM response. In the remaining 60% of recordings, response latencies are severely increased compared to controls. Following frequencies after a train of stimulations at 100 Hz are significantly reduced compared to wild type. Neither presynaptic expression under the control of Scer\GAL4c42.2, or post-synaptic (Scer\GAL4shakB.lethal.4.1) significantly affects the response latency, but the ability of the GF-TTMn to TTM pathway to follow repetitive stimulations is significantly reduced to ~50% using either GAL4 line.

Giant Fibre neuron morphology is disrupted in flies expressing Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4OK307. The synaptic terminal is abnormally thin and the axon as well as the synaptic terminal contains prominent vacuoles. Levels of cell death are similar to controls, and the neurons of the GF circuit are present in all animals.

Expression of Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR.PU causes a mild rough eye phenotype.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Enhanced by
NOT Enhanced by
Enhancer of
Additional Comments
Genetic Interactions
Statement
Reference

Co-expression of one copy each of CG8316d01774 and Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR.PU enhances the rough eye phenotype seen when either transgene is expressed alone.

One copy of CG15599EY06842 enhances the rough eye phenotype seen when Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 is expressed under the control of Scer\GAL4GMR.PU.

One copy of CR43132EY02909 does not enhance the rough eye phenotype seen when Aats-glyP234KY.Scer\UAS.T:Ivir\HA1 is expressed under the control of Scer\GAL4GMR.PU.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Symbol Synonym
Aats-glyP234KY.Scer\UAS.T:Ivir\HA1
GlyRSP234KY.Scer\UAS.T:Ivir\HA1
GlyRSP234KY.UAS.Tag:HA
Name Synonyms
Secondary FlyBase IDs
    References (4)